[1]周莹乔综述,杨剑审校.Gilbert综合征及UGT1A1基因多态性研究进展[J].医学研究与战创伤救治(原医学研究生学报),2018,20(02):181-184.[doi:10.3969/j.issn.1672-271X.2018.02.017]

点击复制

Gilbert综合征及UGT1A1基因多态性研究进展()

分享到62.8K

参考文献/References:

[1]Tan TC, Da Costa JL. Gilbert′s disease［J］. Singapore Med J, 1967, 8(2): 123-125.
[2]Hirschfield GM, Alexander GJ. Gilbert′s syndrome: an overview for clinical biochemists［J］. Ann Clin Biochem, 2006, 43(Pt 5): 340-343.
[3]Strassburg CP. Gilbert-Meulengracht′s syndrome and pharmacogenetics: is jaundice just the tip of the iceberg?［J］Drug Metab Rev, 2010, 42(1): 168-181.
[4]Strassburg CP. Pharmacogenetics of Gilbert′s syndrome［J］. Pharmacogenomics, 2008, 9(6): 703-715.
[5]Fretzayas A, Moustaki M, Liapi O, et al. Gilbert syndrome［J］. Eur J Pediatr, 2012, 171(1): 11-15.
[6]郭栋,庞良芳,周宏灏.尿苷二磷酸葡萄糖醛酸基转移酶基因多态性的研究进展［J］.生理科学进展,2010,41（2）:107-111.
[7]Sugatani J. Function, genetic polymorphism, and transcriptional regulation of human UDP-glucuronosyltransferase (UGT) 1A1［J］. Drug Metab Pharmacokinet, 2013, 28(2): 83-92.
[8]Raijmakers MT, Jansen PL, Steegers EA, et al. Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene［J］. J Hepatol, 2000, 33(3): 348-351.
[9]Canu G, Minucci A, Zuppi C, et al. Gilbert and Crigler Najjar syndromes: an update of the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene mutation database［J］. Blood Cells Mol Dis, 2013, 50(4): 273-280.
[10]D′Angelo R, Rinaldi C, Donato L, et al. The combination of new missense mutation with [A(TA)7TAA] dinucleotide repeat in UGT1A1 gene promoter causes Gilbert′s syndrome［J］. Ann Clin Lab Sci, 2015, 45(2): 202-205.
[11]Matsui K, Maruo Y, Sato H, et al. Combined effect of regulatory polymorphisms on transcription of UGT1A1 as a cause of Gilbert syndrome［J］. BMC Gastroenterol, 2010, 10: 57.
[12]Kringen MK, Piehler AP, Grimholt RM, et al. Serum bilirubin concentration in healthy adult North-Europeans is strictly controlled by the UGT1A1 TA-repeat variants［J］. PLoS One, 2014, 9(2): e90248.
[13]Huang CS. Molecular genetics of unconjugated hyperbilirubinemia in Taiwanese［J］. J Biomed Sci, 2005, 12(3): 445-450.
[14]Hu RT, Wang NY, Huang MJ, et al. Multiple variants in UGT1A1 gene are factors to develop indirect hyper-bilirubinemia［J］. Hepatobiliary Surg Nutr, 2014, 3(4): 194-198.
[15]Johnson AD, Kavousi M, Smith AV, et al. Genome-wide association meta-analysis for total serum bilirubin levels［J］. Hum Mol Genet, 2009, 18(14): 2700-2710.
[16]姥义,徐永利,桑玉顺.阻塞性黄疸的超声诊断［J］.东南国防医药,2003,5（4）:277-278.
[17]Claridge LC, Armstrong MJ, Booth C, et al. Gilbert′s syndrome［J］. BMJ, 2011, 342: d2293.
[18]Teich N, Lehmann I, Rosendahl J, et al. The inverse starving test is not a suitable provocation test for Gilbert′s syndrome［J］. BMC Res Notes, 2008, 1: 35.
[19]Hsieh TY, Shiu TY, Chu NF, et al. Rapid molecular diagnosis of the Gilbert′s syndrome-associated exon 1 mutation within the UGT1A1 gene［J］. Genet Mol Res, 2014, 13(1): 670-679.
[20]Song J, Sun M, Li J, et al. Three-dimensional polyacrylamide gel-based DNA microarray method effectively identifies UDP-glucuronosyltransferase 1A1 gene polymorphisms for the correct diagnosis of Gilbert′s syndrome［J］. Int J Mol Med, 2016, 37(3): 575-580.
[21]Floreani A, Corsi N, Martines D, et al. No effect of endurance exercise on serum bilirubin in healthy athletes and with congenital hyperbilirubinemia (Gilbert′s syndrome) ［J］. J Sports Med Phys Fitness, 1993, 33(1): 79-82.
[22]Chang JL, Bigler J, Schwarz Y, et al. UGT1A1 polymorphism is associated with serum bilirubin concentrations in a randomized, controlled, fruit and vegetable feeding trial［J］. J Nutr, 2007, 137(4): 890-897.
[23]张情梅,任榕娜.新生儿高胆红素血症远期神经心理发育的相关研究［J］.东南国防医药,2016,18（5）:479-482.
[24]Long J, Zhang S, Fang X, et al. Association of neonatal hyperbilirubinemia with uridine diphosphate-glucuronosyltransferase 1A1 gene polymorphisms: meta-analysis［J］. Pediatr Int, 2011, 53(4): 530-540.
[25]Zaja O, Tiljak MK, Stefanovic M, et al. Correlation of UGT1A1 TATA-box polymorphism and jaundice in breastfed newborns-early presentation of Gilbert′s syndrome［J］. J Matern Fetal Neonatal Med, 2014, 27(8): 844-850.
[26]王嶙峰.老年人胆囊炎和胆石症的治疗［J］.南京部队医药,2001,3(1):43-44.
[27]AlFadhli S, Al-Jafer H, Hadi M, et al. The effect of UGT1A1 promoter polymorphism in the development of hyperbilirubinemia and cholelithiasis in hemoglobinopathy patients［J］. PLoS One, 2013, 8(10): e77681.
[28]Chu CH, Yang AM, Kao JH, et al. Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism is associated with choledocholithiasis in Taiwanese patients［J］. J Gastroenterol Hepatol, 2009, 24(9): 1559-1561.
[29]范铁艳,陈虹,王旭,等.肝移植术后Gilbert综合征的诊断［J］.中国急救复苏与灾害医学杂志, 2011,6(7):664-668.
[30]Kaneko J, Sugawara Y, Maruo Y, et al. Liver transplantation using donors with Gilbert syndrome［J］. Transplantation, 2006, 82(2): 282-285.
[31]Lin JP, O′Donnell CJ, Schwaiger JP, et al. Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study［J］. Circulation, 2006, 114(14): 1476-1481.
[32]Tang KS, Chiu HF, Chen HH, et al. Link between colorectal cancer and polymorphisms in the uridine-diphosphoglucuronosyltransferase 1A7 and 1A1 genes［J］. World J Gastroenterol, 2005, 11(21): 3250-3254.
[33]Duguay Y, McGrath M, Lepine J, et al. The functional UGT1A1 promoter polymorphism decreases endometrial cancer risk［J］. Cancer Res, 2004, 64(3): 1202-1207.
[34]Hu ZY, Yu Q, Pei Q, et al. Dose-dependent association between UGT1A1*28 genotype and irinotecan-induced neutropenia: low doses also increase risk［J］. Clin Cancer Res, 2010, 16(15): 3832-3842.
[35]Rasool A, Sabir S, Ashlaq M, et al. Gilbert′s Syndrome - a Concealed Adversity for Physicians and Surgeons［J］. J Ayub Med Coll Abbottabad, 2015, 27(3): 707-710.

相似文献/References: